Jitwatcharakomol, Tanun
Gokun, Yevgeniya
Daniel, Sierra J.
Mestres-Villanueva, Mariella
Young, Rebekah L.
Eckstein, Jacob M.
Andraos, Therese Y.
Healy, Erin H.
White, Julia R.
Bazan, Jose G. Jr
Kumar, Pavnesh
Cochran, Eric R.
Beyer, Sasha J.
Jhawar, Sachin R.
Article History
Received: 18 November 2025
Accepted: 16 February 2026
First Online: 23 February 2026
Declarations
:
: This retrospective, single-institution cohort study was conducted at The Ohio State University Wexner Medical Center in Columbus, Ohio, United States. Before starting the research, its protocol was approved by the Ohio State University Comprehensive Cancer Center Institutional Review Board (IRB Approval Number: 2024C0026). The study was conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments. The requirement for informed consent was waived due to the retrospective nature of the study.
: Not applicable. This manuscript does not contain any individual person’s data.
: Dr. Sachin R. Jhawar reports receiving a research grant from Varian Medical Systems and serving as a consultant and advisory board member for Embiosys and Enlace Health. All other authors declare no competing interests.